Burden of Pneumococcal Disease and Adult Vaccination Landscape: An Overview With Data and Policy Insights From Turkiye
| dc.contributor.author | Durusu-Tanriover, Mine | |
| dc.contributor.author | Adak, Mine | |
| dc.contributor.author | Cicekcioglu, Hulya | |
| dc.contributor.author | Ozger, Hasan Selcuk | |
| dc.contributor.author | Zeren-Ozturk, Guzin | |
| dc.contributor.author | Sonmezer, Meliha Cagla | |
| dc.contributor.author | Sayiner, Abdullah | |
| dc.contributor.author | Adaş, Mine | |
| dc.date.accessioned | 2026-01-25T16:24:16Z | |
| dc.date.available | 2026-01-25T16:24:16Z | |
| dc.date.issued | 2025-12-15 | |
| dc.description.abstract | Streptococcus pneumoniae (pneumococcus) is responsible for various non-invasive and invasive infections and remains a major source of morbidity and mortality, particularly among older adults and at-risk adults. Vaccination is an effective way to prevent pneumococcal disease, and pneumococcal vaccines have been part of national immunization programs for many years. While vaccination coverage is high in children, uptake among older adults and at-risk adult populations remains below desired levels. This article aimed to highlight the burden of pneumococcal disease in adults, review current pneumococcal vaccines, and present a comprehensive overview supported by data from Turkiye. | en_US |
| dc.description.sponsorship | Pfizer | en_US |
| dc.description.sponsorship | has participated in an honorarium-based advisory board meeting organized by Pfizer. Hasan Selcuk Ozger received honoraria from Pfizer, payments from Pfizer and GSK for presentations or lectures; and participated on the Pfizer Advisory Board, outside of the submitted work. BurcinYaz & imath;c & imath; is employed by Pfizer. Onur Saydam is funded by Pfizer for medical writing for the submitted work and is also an employee of Pfizer. Orhan Aydo & gbreve;du is employed by Pfizer. Abdullah Say & imath;ner has received individual consulting fees and payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing or educational events from Pfizer, outside of the submitted work. Mine Ada & scedil;, Guzin Zeren-Ozturk, and Meliha Ca & gbreve;la Sonmezer have no conflicts of interest to declare. | en_US |
| dc.description.sponsorship | Conflict of Interest: Mine Durusu-Tanrıöver has received grants or contracts from Sanofi Pasteur; consulting fees from Sanofi Pasteur, Pfizer, Abbott, GSK, and MSD; and payment or honoraria for lectures and educational events from Sanofi Pasteur, Pfizer, and Abbott; and support for attending meetings from Sanofi Pasteur, Pfizer, and GSK, outside of the submitted work. Hülya Çiçekçioğlu has participated in an honorarium-based advisory board meeting organized by Pfizer. Hasan Selçuk Özger received honoraria from Pfizer, payments from Pfizer and GSK for presentations or lectures; and participated on the Pfizer Advisory Board, outside of the submitted work. Burçin Yazıcı is employed by Pfizer. Onur Saydam is funded by Pfizer for medical writing for the submitted work and is also an employee of Pfizer. Orhan Aydoğdu is employed by Pfizer. Abdullah Sayıner has received individual consulting fees and payment or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing or educational events from Pfizer, outside of the submitted work. Mine Adaş, Güzin Zeren-Öztürk, and Meliha Cağla Sönmezer have no conflicts of interest to declare. | |
| dc.description.sponsorship | has participated in an honorarium-based advisory board meeting organized by Pfizer. Hasan Selcuk Ozger received honoraria from Pfizer, payments from Pfizer and GSK for presentations or lectures; and participated on the Pfizer Advisory Board, outside of the submitted work. BurcinYazıcı is employed by Pfizer. Onur Saydam is funded by Pfizer for medical writing for the submitted work and is also an employee of Pfizer. Orhan Aydoğdu is employed by Pfizer. Abdullah Sayıner has received individual consulting fees and payment or honoraria for lectures, presentations, speakers' bureaus, manuscript writing or educational events from Pfizer, outside of the submitted work. Mine Adaş, Guzin Zeren-Ozturk, and Meliha Cağla Sonmezer have no conflicts of interest to declare. | |
| dc.identifier.doi | 10.36519/idcm.2025.757 | |
| dc.identifier.issn | 2667-646X | |
| dc.identifier.scopus | 2-s2.0-105026376165 | |
| dc.identifier.uri | https://doi.org/10.36519/idcm.2025.757 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/8596 | |
| dc.language.iso | en | en_US |
| dc.publisher | Doc Design Informatics Co Ltd | en_US |
| dc.relation.ispartof | Infectious Diseases and Clinical Microbiology | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Adult | en_US |
| dc.subject | Pneumococcal | en_US |
| dc.subject | Vaccine | en_US |
| dc.title | Burden of Pneumococcal Disease and Adult Vaccination Landscape: An Overview With Data and Policy Insights From Turkiye | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Tanriover, Mine Durusu/0000-0001-9565-4389 | |
| gdc.author.scopusid | 55665934300 | |
| gdc.author.scopusid | 19033400300 | |
| gdc.author.scopusid | 13411166900 | |
| gdc.author.scopusid | 35503742500 | |
| gdc.author.scopusid | 57213103531 | |
| gdc.author.scopusid | 57004610800 | |
| gdc.author.scopusid | 60264170600 | |
| gdc.author.scopusid | 6701356820 | |
| gdc.author.wosid | Saydam, Onur/Aam-7951-2020 | |
| gdc.author.wosid | Zeren Ozturk, Guzin/G-9037-2018 | |
| gdc.author.wosid | Sonmezer, Meliha Cagla/A-9514-2018 | |
| gdc.author.wosid | Çiçekçioğlu, Hülya/Iap-2060-2023 | |
| gdc.author.wosid | Tanriover, Mine Durusu/I-9039-2013 | |
| gdc.author.wosid | zeren ozturk, guzin/GQP-0518-2022 | |
| gdc.author.wosid | ozger, Hasan selcuk/JWA-5110-2024 | |
| gdc.coar.access | open access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü | en_US |
| gdc.description.departmenttemp | [Durusu-Tanriover, Mine] Hacettepe Univ, Inst Vaccine, Ankara, Turkiye; [Adak, Mine] Univ Hlth Sci, Prof Dr Cemil Tascioglu City Hosp, Dept Endocrinol & Metab Dis, Istanbul, Turkiye; [Cicekcioglu, Hulya] Ankara Bilkent City Hosp, Cardiol Dept, Ankara, Turkiye; [Ozger, Hasan Selcuk] Koc Univ Hosp, KUISCID, Istanbul, Turkiye; [Zeren-Ozturk, Guzin] Univ Hlth Sci, Sisli Hamidiye Etfal Training & Res Hosp, Dept Family Med, Istanbul, Turkiye; [Sonmezer, Meliha Cagla] Hacettepe Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Ankara, Turkiye; [Yazici, Burcin; Saydam, Onur; Aydogdu, Orhan] Pfizer Biopharmaceut, Primary Care Vaccine, Istanbul, Turkiye; [Sayiner, Abdullah] Izmir Univ Econ, Sch Med, Dept Chest Dis, Izmir, Turkiye | en_US |
| gdc.description.endpage | 349 | en_US |
| gdc.description.issue | 4 | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q4 | |
| gdc.description.startpage | 337 | en_US |
| gdc.description.volume | 7 | en_US |
| gdc.description.woscitationindex | Emerging Sources Citation Index | |
| gdc.description.wosquality | Q4 | |
| gdc.identifier.openalex | W7122388534 | |
| gdc.identifier.pmid | 41551073 | |
| gdc.identifier.wos | WOS:001649295900001 | |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.openalex.fwci | 0.0 | |
| gdc.openalex.normalizedpercentile | 0.74 | |
| gdc.opencitations.count | 0 | |
| gdc.plumx.scopuscites | 0 | |
| gdc.scopus.citedcount | 0 | |
| gdc.virtual.author | Sayıner, Abdullah | |
| gdc.wos.citedcount | 0 | |
| relation.isAuthorOfPublication | 9421efd7-5180-4b8e-8740-8e75af66ced3 | |
| relation.isAuthorOfPublication.latestForDiscovery | 9421efd7-5180-4b8e-8740-8e75af66ced3 | |
| relation.isOrgUnitOfPublication | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd |